Response in post-menopausal patients on ICI 118630.
作者信息
Robertson J F, Blamey R W
出版信息
Br J Cancer. 1987 Apr;55(4):468. doi: 10.1038/bjc.1987.93.
Abstract
摘要
相似文献
1
Response in post-menopausal patients on ICI 118630.绝经后患者对ICI 118630的反应。
Br J Cancer. 1987 Apr;55(4):468. doi: 10.1038/bjc.1987.93.
2
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.在使用促黄体生成激素释放激素激动剂ICI 118630治疗期间绝经后乳腺癌的缓解情况。
Br J Cancer. 1986 Dec;54(6):903-9. doi: 10.1038/bjc.1986.260.
3
Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.促性腺激素释放激素激动剂类似物疗法对卵巢颗粒细胞瘤有效。
Gynecol Oncol. 1989 Dec;35(3):406-8. doi: 10.1016/0090-8258(89)90089-9.
4
Zoladex in the treatment of premenopausal metastatic breast cancer patients.戈舍瑞林治疗绝经前转移性乳腺癌患者
Horm Res. 1989;32 Suppl 1:202-5. doi: 10.1159/000181346.
5
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.4-羟基雄烯二酮单独及联合戈舍瑞林对绝经前晚期乳腺癌女性的临床及内分泌影响。
Br J Cancer. 1990 Oct;62(4):679-83. doi: 10.1038/bjc.1990.356.
6
Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.促黄体生成素释放激素激动剂对乳腺癌和前列腺癌生长及激素环境的影响。
Chemioterapia. 1985 Jun;4(3):249-51.
7
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.促黄体生成素释放激素激动剂（ICI 118630，诺雷德）在绝经前晚期乳腺癌中的应用。
Br J Cancer. 1986 May;53(5):629-36. doi: 10.1038/bjc.1986.106.
8
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.血清铁蛋白作为III期和IV期乳腺癌治疗反应的标志物。
Eur J Surg Oncol. 1990 Feb;16(1):22-7.
9
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.戈舍瑞林（诺雷德）用于绝经前晚期乳腺癌：缓解持续时间和生存期
Br J Cancer. 1990 Nov;62(5):868-70. doi: 10.1038/bjc.1990.397.
10
Goserelin--the British multicentre trial.戈舍瑞林——英国多中心试验
Br J Clin Pract Suppl. 1989 Nov;68:33; discussion 49-53.
本文引用的文献
1
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.在使用促黄体生成激素释放激素激动剂ICI 118630治疗期间绝经后乳腺癌的缓解情况。
Br J Cancer. 1986 Dec;54(6):903-9. doi: 10.1038/bjc.1986.260.
2
Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.晚期乳腺癌治疗反应评估：瑞士日内瓦国际抗癌联盟临床肿瘤学项目。
Cancer. 1977 Mar;39(3):1289-94. doi: 10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f.
Zotero 插件